Helicobacter pylori

CHAPTER 50 Helicobacter pylori




Helicobacter pylori are unique bacteria ideally suited to live in the acidic environment of the human stomach. Their spiral shape and multiple unipolar flagella allow them to move freely through the gastric mucous layer, where they remain protected from low gastric pH.1 Organisms produce large amounts of urease, an enzyme that hydrolyzes urea to alkaline ammonia and CO2. This permits the bacteria to further control the pH of their microenvironment. Urease is also the basis of clinical diagnostic tests (urea breath test and rapid urea biopsy tests) for infection. H. pylori remain difficult and tedious to culture because they grow slowly and require specialized culture media and a controlled microaerophilic environment.


When they gain access to a human host, H. pylori recognize and attach to various gastric epithelial surface receptors, thereby chronically colonizing the mucosa, disrupting cell function, inciting an intense local inflammatory and systemic immune response, and altering acid secretory physiology.2,3 The ultimate clinical manifestations of H. pylori infection include gastric and duodenal ulcer, gastric mucosa–associated lymphoid tissue (MALT) lymphoma, and adenocarcinoma; yet most infected individuals remain asymptomatic for life despite developing chronic histologic gastritis.1,2,4,5 What factors determine why some develop disease in response to infection and others do not remains a mystery, but host genetics, bacterial characteristics, and environmental features undoubtedly can influence clinical outcome.5,6 Research focusing on epidemiology, pathogenesis, management, and prevention of H. pylori infection and associated clinical conditions continues to be fueled by the tremendous worldwide prevalence of infection (especially in less-developed countries), the huge health and economic burden imposed by ulcer disease and gastric cancer, and heightened prominence and awareness of the bacteria accompanying Drs. Robin Warren and Barry Marshall’s receipt of the 2005 Nobel Prize in Physiology or Medicine for seminal contributions to the field.7



EPIDEMIOLOGY


Helicobacter pylori infection remains one of the most common chronic bacterial infections in humans. Estimates suggest that more than 50% of the world’s population is infected with the bacterium and genetic sequence analysis proposes that humans have been infected for more than 58,000 years at a time when they first migrated from Africa.8


While H. pylori have been demonstrated worldwide in individuals of all ages, infection is more common and acquired at an earlier age in developing countries compared with industrialized nations.9,10 In developing nations, the majority of children become infected before the age of 10, and during early childhood spontaneous elimination of bacteria and subsequent reinfection is quite common. Infection persists in older children and adults so that in the developing areas of the world H. pylori prevalence can reach more than 80% by age 50. In developed countries, such as the United States, young children can also acquire H. pylori, but usually before age 5.11 Spontaneous clearance often occurs and there is less chance of reinfection; thus, persistent childhood infection is much less frequently seen than in less-developed countries.9 In fact, serologic evidence of H. pylori is uncommon in children before age 10, but rises to 10% in adults between 18 and 30 years of age and further increases to 50% in those 60 or older.9 This increased prevalence of infection with age was initially thought to represent continuing acquisition throughout adult life. However, new adult infection and reinfection are quite uncommon, especially in developed countries. Epidemiologic evidence supports childhood-acquired infection even in developed nations, so the frequency of H. pylori infection for any age group in any locality reflects that particular birth cohort’s rate of bacterial acquisition early in life.9 In the United States, within any age group, infection appears to be more common in blacks than whites.12 Also Hispanic immigrants and their first-generation children are more likely to harbor H. pylori than their second-generation relatives.13 These differences probably relate to factors early in life that are linked to acquiring infection.


The risk of acquiring H. pylori is associated with living conditions and the family’s socioeconomic status during one’s childhood.9 Housing density, crowded conditions in the home, number of siblings, sharing a bed, and lack of hot or running water have been linked to higher rates of infection. In Japan, the rapidly declining prevalence of H. pylori appears to parallel the nation’s postwar economic progress and improvement in hygiene and sanitation. Of the Japanese born before 1950, more than 70% are infected compared with 45% born between 1950 and 1960 and 25% born between 1960 and 1970.14 Presently, childhood infection in Japan is rare. Predictions based on a similar declining prevalence in the United States suggest that the organism could eventually become extinct here and in other areas of the world, which would affect infection-related illness.15


Twin studies support genetic susceptibility to H. pylori infection because monozygotic twins who were raised in different households have a greater concordance of infection than dizygotic twins also raised separately.16 However, twins growing up together have a higher concordance of H. pylori status than twins growing up separately, suggesting childhood environmental factors are also important for acquisition.


Humans appear to be the major reservoir of H. pylori. However, domestic cats and captive primates and sheep can harbor these organisms,10 although it is possible that these animals actually acquired H. pylori from a human source. In the case of cats, isolation of viable bacteria from saliva and gastric juice suggests at least the possibility of transmission to humans.10


Especially in developing countries, contaminated water might serve as an environmental source of bacteria because the organism can remain viable for several days in water.17 Bacterial deoxyribonucleic acid (DNA) can be found in samples of municipal water from endemic areas of infection but whether viable H. pylori are present remains to be proven.5 In countries where infection is common, children who drink untreated stream water, eat uncooked vegetables, or swim in rivers and streams are more likely to harbor the bacteria, providing further indirect evidence of an environmental source of organisms.


Person-to-person transmission of bacteria from fecal-oral, oral-oral, or gastro-oral exposure seems the most probable explanation for infection.5,10 Within-family clustering of infection (often with genetically identical strains of H. pylori) supports person-to-person transmission.9 Also infected individuals more often have infected spouses or children than uninfected individuals. Support for sibling-to-sibling transmission comes from studies reporting that likelihood of infection correlated with number of children in the household and that younger children were more apt to be infected if older siblings were also infected.9 Mother-to-child transmission is also quite likely.11,18


Fecal-oral transmission of bacteria is a possible mechanism by which H. pylori gain access to the human host. The bacterium can be cultured from diarrheal stools and vomitus, suggesting the potential for transmission.19 Exposure to an infected family member during an acute gastrointestinal illness, especially with vomiting, appears to be a risk factor for subsequent infection.20


How frequently bacteria are transmitted through oral-oral contact is not known. Although organisms can be identified in dental plaque and saliva, the prevalence is low and it is questionable if the mouth serves as a source or reservoir for H. pylori.21 Also dentists and oral hygienists who continually have occupational exposure to dental plaque and oral secretions do not have a higher prevalence of H. pylori.22 In developed countries, spousal transmission of infection also appears to be uncommon.


Infected gastric secretions can serve as a source of bacterial transmission. Iatrogenic infection has occurred during the use of a variety of inadequately disinfected gastric devices, endoscopes, and endoscopic accessories.10 Also gastroenterologists and nurses appear to be at greater risk for acquiring H. pylori, presumably due to occupational contact with infected gastric secretions.23 Mandated universal precautions, standardized equipment disinfection, and use of video-endoscopes that reposition the instrument channel away from the mouth should reduce such iatrogenic and occupational transmission. Natural transmission could occur through contact with infected vomitus during an acute illness20 or with regurgitated material from an infected child. Such contact could explain the higher concordance of maternal/child H. pylori infection and the presumed child-to-child transmission that occurs in an infant daycare setting.24




COLONIZATION AND VIRULENCE FACTORS


One of the interesting aspects of this pathogen is how it confers disease when the organism resides, for the most part, in the lumen. Studies describing the genome of two distinct strains of H. pylori have helped to advance our understanding of the ecology of the organism and the potential gene expression patterns that can affect the pathogenesis of disease.25,26 Importantly, bacterial genes expressed in gastric mucosa differ from the pattern observed in vitro,27 whereas exposure of the bacterium to low pH increases its expression of genes encoding proteins involved in the motility apparatus and of genes encoding urease.28 The urease helps the organism adapt to the gastric milieu as it retains optimal function at two different pH values: usually pH 7.2 and pH 3.29 H. pylori is further adapted to the gastric pH by producing the molecular machinery required to migrate rapidly to a more favorable environment below the mucus layer. Motility is one of the few H. pylori characteristics shown to be necessary for successful colonization of the host.


H. pylori show a strict tropism for the gastric mucosa or intestinal sites in which there is gastric metaplasia. The corollary is also true, as H. pylori do not colonize epithelium in the stomach that has undergone intestinal metaplastic change, possibly due to the production of antimicrobial factors that select against colonization. This possibility is supported by the fact that H. pylori rarely colonize the deeper portions of the gastric glandular mucosa, where O-glycans that impair H. pylori growth are found.30 This concept is also supported by another study that shows H. pylori decreases the expression of the antibacterial molecule, secretory leukocyte protease inhibitor,31 thereby removing an element of the host response that would be detrimental to the persistent infection.


Another important factor that controls colonization is the expression of receptors on host cells that allow H. pylori to bind. Lewis (Le) antigens expressed by host cells serve as a receptor for bacterial binding.32 Specific bacterial gene products, most notably BabA, act as the bacterial ligand for the Leb receptor.33 The Leb receptor may be located in the gastric mucus because strains bearing BabA also bind to the mucin MUC5AC.34 Some studies suggest that the babA2 genotype is more frequently associated with inflammation, duodenal ulcer and gastric cancer.2 However, observations that binding of H. pylori to epithelial cells freshly isolated from human gastric biopsy specimens is unaffected by the expression of Le antigen, that infection is not increased in subjects with the Leb phenotype, and that individuals who do not express Leb can clearly be infected with H. pylori cast doubt on the true role of Leb and BabA.2 Additionally, in one report, the majority of strains infecting the individuals studied did not induce ulcers or cancer, despite expressing the babA2 gene.35


H. pylori also bind to the molecular complex of invariant chain and class II human leukocyte antigens (HLAs) expressed on the surface of gastric epithelial cells.36 Class II major histocompatibility complex (MHC) molecules, with their expression increased by infection, were the first epithelial cell receptor for H. pylori demonstrated to directly affect signaling in host cells. Binding of urease to epithelial cells via class II MHC was sufficient to induce apoptosis.37 More recently, the gastric trefoil protein TFF1 was shown to serve as a receptor for H. pylori.38 This molecule is predominantly expressed in the gastric mucosa and found in association with gastric mucus. In genetically engineered mice with TFF1 deficiency, a spontaneous, antral adenoma develops, suggesting that this molecule provides an element of control over gastric epithelial cell growth.39,40


The pathogen-associated molecular receptors (PAMPS) have also been examined for their role in binding of H. pylori to the host epithelial cells. The Toll-like receptors (TLRs) are a family of PAMPS, with an apparent different specificity for various bacterial molecules.41 For example, TLR4 is able to recognize the LPS of many bacteria, with cytokines and H. pylori particles increasing the expression of TLR4.42 H. pylori LPS stimulates monocytes and gastric epithelial cell responses via TLR4.2 Other PAMPs, including TLR2, are also activated by highly purified H. pylori LPS and have even been described as being more important than TLR4.43,44 These receptors may bind bacterial products, and thereby enhance bacterial binding and cell signaling.42 TLR5 binds bacterial flagellins and, similar to TLR2, induces a signaling response that can trigger acute inflammation. H. pylori produce flagellin that binds TLR5 and activates a response in vitro.43 There is disagreement on which TLR is stimulated by H. pylori LPS or whether H. pylori flagellin is ever able to bind TLR5,45 and this may reflect the different conditions used for bacterial culture and LPS or flagellin purification. Further studies are needed to establish the significance of H. pylori binding to TLRs in the pathogenesis of infection.


After H. pylori migrate to the gastric epithelium, the organism attaches to host cells and may damage them in order to obtain nutrients from the subsequent inflammatory exudate or transudate. A key interaction between the bacteria and gastric epithelium involves a segment of bacterial DNA referred to as the cag pathogenicity island (cag PAI). Genes within the cag PAI encode proteins that provide a type IV secretion apparatus (i.e., cagE) that allows bacterial macromolecules to translocate into the host cell (i.e., cagA).26,46 cag PAI plays an important role in the pathogenesis of gastritis in humans26,47 because H. pylori bearing the cag PAI are associated with increased interleukin-8 (IL-8) expression and inflammation in gastric mucosal biopsy specimens and increased IL-8 expression and apoptosis in vitro.48 Infecting gerbils with mutated strains lacking cagE reduces the severity of gastritis and the development of gastric ulcers, intestinal metaplasia, and gastric cancer compared with gerbils infected with the wild-type strain.48,49 Human studies in which duodenal ulceration occurred more frequently in children carrying strains expressing cagE associated with higher levels of gastric IL-850 corroborate animal and in vitro studies.


All strains of H. pylori possess the vacA gene, with more than half expressing the vacuolating cytotoxin (VacA), which attaches to epithelial cells via an interaction with protein-tyrosine phosphatases.51 Although the majority of the VacA is secreted, some may remain on the surface of the bacteria and serve as a ligand for bacterial attachment via this protein-tyrosine phosphatase receptor. Several studies have examined the structure and function of VacA and its association with disease.26,52,53 For example, mice deficient in protein-tyrosine phosphatase beta do not develop ulceration when exposed to VacA.54 Different vacA alleles have been classified in the 5′ signal region (s-region) and the middle region (m-region) of the vacA gene.52 The s-region is present as s1 (which can be further distinguished as s1a, s1b, s1c) or s2, whereas the m-region is present as m1 or m2. Production of VacA is designated by the allelic combination s1/m1 and s1/m2. Specific vacA alleles (s1 and m1) are associated with disease55 and the induction of epithelial cell apoptosis.56 The interaction between VacA and its receptor(s) appears to be important in the pathogenesis of gastroduodenal disease, whether it serves as a ligand for bacterial attachment or as a secreted virulence factor.



HOST RESPONSE TO INFECTION


Increasing evidence suggests that the host response to H. pylori infection is an intrinsic component of the pathogenesis of gastrointestinal disease (Chapters 29, 52, and 54). The possibility that the host response may play a direct role in gastric cancer is supported by the observation that heterogeneity in the regions of the genome that control the magnitude of inflammation is associated with cancer linked to H. pylori infection.57 Polymorphisms in the regions controlling IL-1β58 were shown to be associated with an increased incidence of hypochlorhydria and gastric cancer. This seminal observation has been replicated in other studies in which IL-1β polymorphisms were associated not only with gastric cancer but also a decrease in recurrence of duodenal ulcer.59 An increase in IL-1 may not only drive inflammation but also lead to a physiologic state known to precede gastric cancer development because IL-1 potently inhibits gastric acid secretion. Increased gastric IL-1, more severe gastritis, gastric atrophy, and greater colonization with H. pylori strains have been associated with gastric cancer.2 Other genes that regulate the magnitude of the inflammatory response, including IL-10, tumor necrosis factor-α (TNF-α), and IL-8, have also been associated with the sequence of events leading to cancer.60,61


It is apparent that epithelial cells play an integral part in the host response to H. pylori infection as well as being the target of infection. The epithelial response to infection is complex, as it is driven by several variables: bacterial virulence factors; the signaling linked to specific receptors that recognize the bacterial components; and the local milieu of hormones, neurotransmitters, immune or inflammatory cytokines and mediators, as well as stromal factors. The epithelial cell responses include changes in epithelial cell morphology (the hummingbird phenotype),62 disruption of the tight junctional complexes,63 the production of cytokines,46 increased epithelial cell proliferation, increased rates of epithelial cell death via apoptosis, and the induction of numerous genes associated with the stress encountered in response to infection.2 The best overview of the epithelial cell response can be ascertained from the broad changes in the expression of hundreds of genes demonstrated with high-throughput gene expression systems.2 Detailed analyses of the effects of infection, different cell lines and various inflammatory mediators have yet to be carried out over the wide range of time points that would be relevant to the conditions epithelial cells face in vivo.


The expression of genes in epithelial cells stimulated with H. pylori is regulated by transcription factors that are controlled by a series of signaling mechanisms. While many transcription factors are likely activated by infection, the most studied are nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) which regulate the expression of a wide variety of proinflammatory cytokines and cellular adhesion molecules in response to infection or the local cytokine milieu. H pylori activates NF-κB in gastric epithelial cells, both in vitro and in vivo in patients with H. pylori gastritis; gastric epithelial cell NF-κB activity is markedly enhanced, correlating with the intensity of neutrophil infiltration and IL-8 protein levels.46 This pathway is of particular interest given the recent report that polymorphisms in the IL-8 gene lead to increased mucosal IL-8 expression, inflammation, and other premalignant changes associated with gastric cancer. H. pylori infection appears to activate NF-κB and AP-1 in gastric epithelial cell lines through various signaling mechanisms including mitogen-activated protein (MAP) kinases.47,64 The MAP kinase cascades regulate a wide range of cell functions, including proliferation, inflammatory responses, and cell survival. For example, cag PAI-positive H. pylori activate the ERK, JNK, and p38 MAP kinase pathways, and ERK and p38 regulate IL-8 production in gastric epithelial cells.65,66 An inhibitor of p38α MAP kinase, FR167653, reduced both neutrophil infiltration and gastric mucosal injury in H. pylori–infected Mongolian gerbils.67


One of the novel concepts emerging is the role of oxidative stress in regulating gene expression during H. pylori infection. Apurinic-apyrimidinic endonuclease-1 (also referred to as redox factor-1) plays a key role in the regulation of redox-sensitive signaling and is expressed in gastric epithelial cells during infection with H. pylori,68 contributing to activation of AP-1 and NF-κB required for the host response to infection, including IL-8 production.69 However, the role it and other redox-regulatory molecules play in the pathogenesis of diseases associated with H. pylori has yet to be clearly defined. Oxidation of DNA by reactive oxygen species such as hydroxyl radicals are thought to play a causal role in malignant transformation through the induction of DNA damage. Oxidative DNA damage is increased in gastric epithelial cells by H. pylori infection. There is growing interest in the role of antioxidants in disease prevention or treatment because infection is associated with decreased levels of a tissue antioxidant scavenger, vitamin C. Moreover, there is evidence that diets high in antioxidants70 or “nutraceuticals” of the isothiocyanate group, such as sulforaphane,71 can antagonize oxidative stress and protect the host from gastric cancer, perhaps by decreasing inflammation and attenuating bacterial load.


CagA protein translocates into the host cell cytoplasm where it is tyrosine phosphorylated by host Src kinases, and through other interactions, regulates epithelial cell morphology.7276 CagA in strains from distinct geographic populations appears to be phosphorylated in a different manner resulting in different effects on intracellular signaling.77,78 It is intriguing to speculate that heterogeneity in the CagA protein may lead to distinct effects on the host response that account for some of the geographic differences in disease. Although phosphorylation of the CagA protein may be important, it is not the only mechanism whereby this molecule regulates the host response. A phosphorylation-independent effect on gene transcription, which is also attributed to the CagA protein, also has been reported.79 Moreover, greater than 30% of host gene expression is altered independently of the phosphorylation of CagA, at least in intestinal epithelial cell lines.80


Outer inflammatory protein A (OipA) is another bacterial product that induces epithelial cell IL-8 production81 and strains that express OipA are associated with increased bacterial density, mucosal IL-8 levels, and neutrophil infiltration, as well as more severe clinical consequences.82 Peptidoglycan has been reported to translocate into gastric epithelial cells via the type IV secretion system encoded by the cag PAI. Once inside the cell these bacterial compounds are recognized by nucleotide-binding oligomerization domain-1 (NOD1), thereby providing a novel mechanism of bacterial sensing.83 Binding to NOD1 can lead to activation of NF-κB and the subsequent expression of various host genes encoding proinflammatory molecules.


As discussed in Chapter 49, gastric acid secretion is a major function of the gastric mucosa that is regulated by a variety of neural, endocrine, and immune factors.3 Elevated fasting and meal- or hormone-stimulated levels of gastrin are well documented in H. pylori infection, and there is evidence that gastrin expression is regulated by bacterial factors and cytokines. Expression of somatostatin, an acid-inhibitory peptide, is diminished in infected individuals as is duodenal bicarbonate secretion. The net effect of H. pylori infection on acid secretion is complex and varies depending on the duration and distribution of infection and presence of mucosal atrophy. Secretion of mucus is also affected by H. pylori infection with decreased amounts of mucus and gastric mucosal hydrophobicity; these abnormalities reverse after eradication of infection. Epithelial barrier function is altered during H. pylori infection as a consequence of both direct effects of H. pylori and the accompanying inflammatory response that collectively increase epithelial cell proliferation and programmed cell death.2


Infection with H. pylori results in a unique inflammatory response in which infection persists despite the recruitment and activation of T and B lymphocytes, phagocytic cells, and other immune cell populations. Whereas several epithelial cell responses to H. pylori have been described earlier, they do not appear to fully account for the magnitude of the inflammatory response to an organism that resides predominantly in the lumen. Some bacteria may infect epithelial cells, and significant amounts of bacterial material may “leak” around epithelial cells and reach the lamina propria, where it can activate underlying phagocytes, including neutrophils and macrophages. One bacterial factor is the H. pylori neutrophil-activating protein (HP-NAP). This 150-kd decamer protein promotes neutrophil adhesion to endothelial cells and stimulates chemotaxis of monocytes and neutrophils, NADPH oxidase complex assembly at the plasma membrane, and the subsequent production of reactive oxygen intermediates (ROIs).84 In the inflammatory environment present during H. pylori gastritis, TNF-α and interferon-γ (IFN-γ) can prime neutrophils and potentate the effects of HP-NAP.


When cells undergo apoptosis and die, they are removed by phagocytes. This response occurs in the digestive tract as epithelial cells migrate toward the lumen and undergo apoptosis, providing another means whereby the host can sample the antigenic challenges facing epithelial cells. Viral antigens are presented to T cells when infected apoptotic epithelial cells overlie the Peyer’s patch. Engulfment of H. pylori infected epithelial cells by phagocytes may also be an important mechanism by which H. pylori can activate the host response, and it has been shown that macrophages bind and then engulf gastric epithelial cells that undergo apoptosis due to infection.2


Recruitment and activation of macrophages and neutrophils cause the release of other inflammatory mediators. Increased expression of inducible nitric oxide synthase (iNOS) is observed in the gastric mucosa during infection with H. pylori.2 Nitric oxide (NO) and superoxide (O2), which may be produced by infiltrating neutrophils, react to form peroxynitrite (ONOO), a potent oxidant and reducing agent. Although these products have potent antimicrobial effects, uncontrolled or inappropriate production could play a role in the gastric mucosal damage observed during H. pylori infection. The catabolism of urea by urease provides CO2, which rapidly neutralizes the bactericidal activity of the peroxynitrate by reacting with it to form ONO-OCO2. Urease may favor bacterial colonization by neutralizing some host responses but this also enhances the nitration potential of ONOO and may favor mutagenesis of host cell DNA.


Cytokines secreted by epithelial cells complement those released in the lamina propria. For example, neutrophils are not only activated by IL-8 but also by chemokines such as ENA-7885 and Gro-α,86 which can derive from the epithelium, the adjacent myofibroblasts or the macrophages within the lamina propria. Cytokine induction in macrophages includes induction of TNF-α and IL-6 by urease,87 whereas heat shock protein 60 induces IL-6.88 Intact bacteria can induce the production of chemokines that recruit T cells,89 as well as IL-1290,91 and IL-18,92 two cytokines that favor the selection of Th1 cells. Thus, intact bacteria or bacterial factors trigger a broad cytokine response within the lamina propria.


As adaptive responses develop, different T lymphocyte helper (Th) cell subsets emerge, with characteristic patterns of cytokine secretion. Th1 cells promote cell-mediated immune responses through the production of IFN-γ and TNF-α, whereas Th2 cells produce IL-4, IL-5, IL-10, and transforming growth factor-β (TGF-β). Th2 cells can promote mucosal IgA or IgE responses, as well as diminish the inflammation caused by Th1 cytokines. Previous studies suggest that the infected gastric mucosa is preconditioned to favor Th1 cell development.90 One possible hypothesis to account for this tendency is that infection selectively blocks Th2 development. H. pylori can interfere with STAT6 activation by IL-4,93 which could impair Th2 development, and IL-12 and IL-18 induced in response to infection may positively select for the predominant Th1 response. Other cytokines that may enhance Th1 responses, such as IL-23 and IL-27, have yet to be studied in human tissue.


T cell activation by H. pylori infection may contribute to more severe inflammation and gastroduodenal diseases. Increased levels of biologically active IL-17, a cytokine produced by activated CD4+ T lymphocytes, are found in the mucosa of H. pylori–infected patients.94,95 IL-17, in turn, induces IL-8 expression by gastric epithelial cells, thereby enhancing neutrophil recruitment. Activation of transcription factors by IL-17 may also contribute to the increased levels of numerous other proinflammatory cytokines and enzymes observed during H. pylori infection, such as IL-1β, TNF-α, and cyclooxygenase-2 (COX-2). IFN-γ and TNF-α produced by Th1 cells can increase the expression of many genes in the epithelium, including IL-8. These cytokines also enhance bacterial binding36 and may contribute to enhanced bacterial load.96 In animal models Th1 cells increase epithelial cell apoptosis36 as well as inflammation, atrophy, and dysplasia.97 TNF-α, IFN-γ, and IL-1β up-regulate gastric mucosal Fas antigen expression.98 Since Th1 cells express higher levels of Fas ligand (FasL) than Th2 cells, the relative increase in Th1 cells during H. pylori infection may induce epithelial cell death through Fas-FasL interactions.98,99 This notion is substantiated by the observation that proton pump H+,K+-ATPase–specific Th1 cells in the gastric mucosa kill target cells via Fas-FasL interactions and may act as effector cells in autoimmune gastritis.100


Because Th1 cells cannot clear H. pylori, some other T cell subset may have to be stimulated in order to confer immunity. Studies in animal models indicate that protective immunity was induced by vaccines for Helicobacter spp. via Th cells other than Th1 cells, possibly including Th2 cells. The anti-inflammatory cytokines associated with Th2 cells or other regulatory subsets of Th cells can attenuate the pathogenic effects of Th1 cells.101 More direct evidence suggests that IL-4 can decrease gastritis, an effect that may be mediated by the release of somatostatin.97 As gastric responses can be modified by Th2 cells, the role of other T cell subsets, such as regulatory T cells (Treg), in the pathogenesis of disease associated with H. pylori infection is being addressed. Depletion of Treg in neonatal mice leads to autoimmune gastritis,102 and infection with H. pylori alleviates autoimmune gastritis induced in neonatal mice.103 This suggests that infection may stimulate a subset of anti-inflammatory T cells that impair excessive inflammation, which could otherwise lead to the spontaneous clearance of the organism, an effect that appears to occur in the human mucosa in response to H. pylori infection.104


Antibodies in the gastrointestinal tract are normally of the immunoglobulin A (IgA) isotype, which are highly adapted for mucosal protection, conferring protective immunity without activating complement and stimulating deleterious amounts of inflammation. During infection with H. pylori, the number of IgA producing cells increases. IgG and IgM are also detected, along with activated complement. It has been suggested that the level of autoantibodies in humans correlates with the severity of gastritis.2 Local immune complexes contribute to gastroduodenal inflammation and tissue damage during infection and may contribute to autoimmune gastritis. Monoclonal antibodies that recognize H. pylori cross-react with human and murine gastric epithelial cells.105,106 Adoptive transfer of these antibodies to recipient mice induces gastritis,105 as does the transfer of B cells that recognize heat shock proteins from individuals with maltoma.107 Anti-Le antibodies have been described in humans and occur independently of the Le phenotype of the host but they do not appear to be autoreactive. Autoantibodies induced in mice may recognize different targets within the gastric mucosa and even though they may cross-react with human gastric tissue, autoantibodies induced in humans may have a completely different specificity.


With few exceptions, infection with H. pylori persists for the life of the host unless there is some intervention with antibiotics. This observation has led to investigations as to whether immunity is impaired by immunologic avoidance or tolerance. Several bacterial factors, including catalase and urease, antagonize innate host responses. Production of the enzyme arginase by H. pylori inhibits NO production and may favor bacterial survival,108 whereas virulent strains of H. pylori have also been shown to alter mucus production109 and phagocytosis.110

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 31, 2016 | Posted by in GASTROENTEROLOGY | Comments Off on Helicobacter pylori

Full access? Get Clinical Tree

Get Clinical Tree app for offline access